Three-year outcomes with the use of dual non-invasive rejection surveillance after heart transplantation
When comparing a rejection surveillance strategy of GEP/biopsy against GEP/ddcfDNA, heart transplant outcomes were similar at 3 years, while a strategy of GEP/ddcfDNA resulted in significantly fewer EMBx.
Authors
- Melody B. Zhang
- Kiran Kaur Khush (ORCID: https://orcid.org/0000-0001-9697-5926)
- Juka S. Kim (ORCID: https://orcid.org/0000-0001-7794-8068)
- E. Henricksen (ORCID: https://orcid.org/0000-0002-4434-584X)
- Joyce Njoroge (ORCID: https://orcid.org/0000-0003-4379-5328)
- Brandon A. Guenthart (ORCID: https://orcid.org/0000-0002-9864-0035)
- Helen Luikart (ORCID: https://orcid.org/0000-0002-9782-4449)
- Roy Lee (ORCID: https://orcid.org/0000-0001-7602-3979)
- Jeffrey J. Teuteberg (ORCID: https://orcid.org/0000-0002-8342-3222)
- Thu H. Le (ORCID: https://orcid.org/0000-0002-6410-1623)
Institutions
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100456
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00